Global corneal implants market is expected to grow at a CAGR of 6.3% during the forecast period. The growth of the market is attributed to the increasing prevalence of corneal diseases and conditions, the growing aging population, and advancements in corneal implant technologies. According to the Centers for Disease Control and Prevention, approximately 12 million people 40 years and over in the US have vision impairment, including 1 million who are blind, 3 million who have vision impairment after correction, and 8 million who have vision impairment due to uncorrected refractive error. Also, according to WHO, Globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion – or almost half – of these cases, vision impairment could have been prevented or has yet to be addressed.
Browse the full report description of “Corneal Implants Market Size, Share & Trends Analysis Report by Tissue Type (Artificial Cornea, and Human Donor), by Corneal Diseases (Fungal keratitis, Fuchs Dystrophy, and Keratoconus), by End-User (Hospitals, Eye Clinics, and Ambulatory Surgical Centers (ASC)), Forecast Period 2023-2030” at https://www.omrglobal.com/industry-reports/corneal-implants-market
In addition, the growing initiatives taken by various governments and organizations to address corneal diseases is anticipated to propel the growth of the market. For instance, in December 2021, BIANCO, which is being launched by Minister for Health and Medical Research Brad Hazzard, received grant funding from the Australian Government through the Medical Research Future Fund 2021 Frontier Health and Medical Research Initiative. BIANCO will bioengineer a total cornea as well as partial thickness grafts for transplant, reducing the amount of donor tissue required. It will take on the global challenge of corneal blindness, the third most common cause of blindness around the globe. Thus the Corneal Implants market is expected to continue growing in the coming years, with significant opportunities for growth in emerging markets and the development of new and innovative corneal implant products.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Tissue Type
o By Corneal Disease
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- AcuFocus, Inc., Addition Technology, Inc., (A Company of AJL Ophthalmic, S.A.), Adverum, Biotechnologies Inc., Alcon (A Division of Novartis AG), Astellas Pharma US, Inc., Bausch & Lomb Inc. and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Corneal Implants Market Report Segment
By Tissue Type
By Corneal Disease
By End-User
Global Corneal Implants Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/corneal-implants-market